Abstract
Lawton et al (1990) observe that metastatic angiosarcoma is a rare condition and is associated with extremely poor survival following the development of lung complications. They also state that, although radical doses of radiotherapy (44–60 Gy over 4–6 weeks, respectively, 4 fractions per week) have been followed by long term control of local disease, this may not necessarily correlate with improved survival. A further case, identified by retrospective review of patients' records of the Skin Unit of the Peter MacCallum Cancer Institute (PMCI) in Melbourne, is described here to report the response to hypofractionated treatment.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
